Assignment of Assignor's Interest

Recorded: 2020-07-02 Pages: 14

Assignor

REGULUS THERAPEUTICS INC.

Executed: 2019-05-08

Assignee

SANOFI

54, RUE LA BOÉTIE, PARIS, 75008, FRANCE

Covered Properties (4)

MicroRNA Compounds and Methods for Modulating MIR-21 Activity

Application: 16/586,216 →

Methods for Treatment of Alport Syndrome

Application: 16/655,085 →

Methods for Treatment of Alport Syndrome

Application: 16/747,837 →

Publication: US 2020/0283765

MicroRNA Compounds and Methods for Modulating MIR-21 Activity

Application: 16/751,402 →

Publication: US 2020/0291400